SEI Investments
ABEO icon

SEI Investments’s Abeona Therapeutics ABEO Stock Holding History

SEI Investments’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$773K Buy
172,460
+101,307
+142% +$506K ﹤0.01% 2478
2025
Q4 		$375K Buy
+71,153
New +$358K ﹤0.01% 2632

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

SEI Investments's ABEO Position: Q1 2026 in Review

SEI Investments increased its Abeona Therapeutics (ABEO) stake by 142% in Q1 2026, buying an estimated $506K and bringing the position to 172,460 shares worth $773K. The position accounts for ﹤0.01% of the portfolio, ranked #2478.

SEI Investments first reported a position in ABEO in Q4 2025 and has held it in 2 quarters since. 108 funds tracked by Wall St. Rank hold ABEO as of Q1 2026.

  • SEI Investments held 172,460 shares of Abeona Therapeutics worth $773K as of Q1 2026.
  • SEI Investments bought 101,307 Abeona Therapeutics shares in Q1 2026, an estimated $506K.
  • Abeona Therapeutics made up ﹤0.01% of SEI Investments's portfolio in Q1 2026, its #2478 holding.
  • SEI Investments first reported a position in Abeona Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • 108 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q1 2026.

Based on SEI Investments's 13F filing for Q1 2026, filed 13 May 2026.